🔬Causal Models Need Causal Data - Xaira’s X-Cell model (Bo Wang & Ci Chu)
This episode delves into Zera Therapeutics' AI drug discovery platform, focusing on their X-Cell model. Guests Bo Wang and Ci Chu explain how X-Cell leverages high-throughput causal data generation (Perturb-seq) and a novel diffusion model architecture with biological priors to predict cellular responses to interventions. They discuss the model's generalization capabilities to unseen biological contexts, the current bottlenecks in virtual cell modeling, and the evolving roles of academia and industry in AI for science.
- Academic freedom isn't a luxury, it's a speed advantage. Bo Wang argues university labs, free from immediate profit pressures, are the wellspring for radically new concepts, like the biological priors behind Zera Therapeutics' X-Cell model. This deep, unconstrained thinking is hard to replicate in… Read →
- Even with advanced AI drug discovery platforms like Zera Therapeutics’ X-Cell model, the current bottleneck for virtual cell modeling isn't just compute power or algorithms, but the type of data we can actually collect. Read →
- Zera Therapeutics' X-Cell model uses a diffusion language model architecture to predict cellular responses, departing from traditional auto-regressive (GPT-like) methods. Read →
- Zera Therapeutics' X-Cell AI, a novel diffusion model, predicts how cells respond to interventions using high-throughput causal data (Perturb-seq). Read →